Brief: Vigil Neuroscience Q2 EPS USD -0.52 Vs. IBES Estimate USD -0.55
Aug 13 (Reuters) - Vigil Neuroscience Q2 operating expenses USD 22.478 million. * Q2 net income USD -21.227 million vs. IBES estimate USD -22 million * Q2 operating income USD -22.478 million vs. IBES estimate USD -22.6 million
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions